Website profile

Psychedelic Alpha

psychedelicalpha.com @PsilocybinAlpha
All articles Clear site filter

We provide information, research, news and interviews from the emergent psychedelic sector in one place.

  • 4articles · 30d
  • 3+ day agolatest article
  • Aug 18, 2026earliest in window
  • 75%with images
  • 329avg words
articles per day
Covers
People
Places
Organizations
Categories
  • Medical 4
  • Health & Wellness 3
  • Health 2
  • Arts, Culture, Entertainment & Media 1
  • Business & Industrial 1
  • Economy, Business & Finance 1
Site tags

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Google News
psychedelicalpha.com > news > scoop-johnson-johnson-to-lead-delix-therapeutics-85m-series-c

Scoop: Johnson & Johnson to Lead Delix Therapeutics??€?? $85M Series C

3+ week, 5+ day ago   (702+ words) 🎟️ Join us at The Psychedelic Business Forum in NYC Johnson & Johnson is set to lead neuroplastogen developer Delix Therapeutics’ $85M Series C round at a $190M pre-money valuation, according to documents reviewed by Psychedelic Alpha. Note: Audio versions of our articles are…...